Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,796 | 14 | 55.3% |
| Consulting Fee | $16,838 | 13 | 21.3% |
| Travel and Lodging | $14,222 | 34 | 18.0% |
| Food and Beverage | $2,328 | 24 | 2.9% |
| Unspecified | $2,000 | 1 | 2.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $69,450 | 69 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $3,780 | 1 | $0 (2020) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $3,045 | 4 | $0 (2024) |
| Novo Nordisk AS | $2,000 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $308.00 | 3 | $0 (2024) |
| Novo Nordisk Health Care AG | $297.46 | 3 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $122.07 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $105.26 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $37.83 | 1 | $0 (2023) |
| Amgen Inc. | $19.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,008 | 69 | Novo Nordisk Inc ($63,724) |
| 2023 | $3,603 | 8 | Novo Nordisk Inc ($3,207) |
| 2022 | $2,652 | 5 | Novo Nordisk Inc ($2,520) |
| 2021 | $2,122 | 2 | Novo Nordisk AS ($2,000) |
| 2020 | $3,798 | 2 | Alnylam Pharmaceuticals Inc. ($3,780) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,837.50 | General |
| Category: Rare Disease | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $853.89 | General |
| Category: Rare Disease | ||||||
| 10/26/2024 | Novo Nordisk Health Care AG | — | Food and Beverage | In-kind items and services | $44.52 | General |
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $111.33 | General |
| 10/08/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,162.50 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $548.90 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $418.06 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $214.64 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $113.60 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,162.50 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $908.89 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $346.70 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $181.46 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $144.58 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,937.50 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $464.90 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $322.00 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Travel and Lodging | In-kind items and services | $189.20 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $57.67 | General |
| Category: Rare Disease | ||||||
| 09/13/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,812.50 | General |
| 09/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $664.72 | General |
| 09/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $250.18 | General |
| 09/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $200.49 | General |
| 09/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $110.77 | General |
About Dr. Prasad Devarajan, M.D
Dr. Prasad Devarajan, M.D is a Pediatric Nephrology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235216011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prasad Devarajan, M.D has received a total of $79,184 in payments from pharmaceutical and medical device companies, with $67,008 received in 2024. These payments were reported across 86 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,796).
Practice Information
- Specialty Pediatric Nephrology
- Location Cincinnati, OH
- Active Since 11/01/2006
- Last Updated 03/13/2015
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1235216011
Products in Payments
- Rivfloza (Drug) $24,339
- OXLUMO (Drug) $3,780
- Crysvita (Drug) $122.07
- BENLYSTA (Biological) $105.26
- ULTOMIRIS (Biological) $64.36
- PROCYSBI (Biological) $19.50
- Carpediem (Device) $18.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in Cincinnati
Stuart Goldstein, Md, MD
Pediatric Nephrology — Payments: $421,287
Hillarey Stone
Pediatric Nephrology — Payments: $5,121
Kyle Mccracken, M.d., Ph.d, M.D., PH.D
Pediatric Nephrology — Payments: $122.85
Mark Mitsnefes, M.d, M.D
Pediatric Nephrology — Payments: $109.80
Elif Erkan, Md, MD
Pediatric Nephrology — Payments: $89.14
Dr. Jean-Philippe Roy, Md, MD
Pediatric Nephrology — Payments: $50.48